Nothing Special   »   [go: up one dir, main page]

ATE375141T1 - Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer - Google Patents

Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer

Info

Publication number
ATE375141T1
ATE375141T1 AT01914710T AT01914710T ATE375141T1 AT E375141 T1 ATE375141 T1 AT E375141T1 AT 01914710 T AT01914710 T AT 01914710T AT 01914710 T AT01914710 T AT 01914710T AT E375141 T1 ATE375141 T1 AT E375141T1
Authority
AT
Austria
Prior art keywords
eye
compositions
treating
preventing diseases
posterior chamber
Prior art date
Application number
AT01914710T
Other languages
English (en)
Inventor
Erwin Si
Lyle Bowman
Cheryl Rowe-Rendleman
Samir Roy
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/523,102 external-priority patent/US7141607B1/en
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of ATE375141T1 publication Critical patent/ATE375141T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01914710T 2000-03-10 2001-03-07 Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer ATE375141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/523,102 US7141607B1 (en) 2000-03-10 2000-03-10 Methods and compositions for treating and inhibiting retinal neovascularization
US64844600A 2000-08-28 2000-08-28

Publications (1)

Publication Number Publication Date
ATE375141T1 true ATE375141T1 (de) 2007-10-15

Family

ID=27061037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914710T ATE375141T1 (de) 2000-03-10 2001-03-07 Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer

Country Status (9)

Country Link
EP (2) EP1938799B1 (de)
JP (1) JP2003529567A (de)
KR (1) KR20010113918A (de)
AT (1) ATE375141T1 (de)
AU (1) AU785285B2 (de)
CA (1) CA2373237A1 (de)
DE (1) DE60130872T2 (de)
MX (1) MXPA01011346A (de)
WO (1) WO2001068053A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009868A1 (en) * 2001-07-26 2003-02-06 Otago Innovation Limited Antigenic compositions
AP1750A (en) * 2001-11-09 2007-06-23 Eyetech Pharmaceuticals Methods for treating ocular neovascular diseases
EP2327400A3 (de) * 2003-03-14 2011-10-19 University of Washington Retinoid-ersatz und opsin-agonisten und anwendungsverfahren dafür
JP2007523911A (ja) * 2004-02-26 2007-08-23 アドバンスト アキュラー システムズ リミテッド 眼病変治療用テトラサイクリン誘導体
RU2554003C2 (ru) 2004-06-18 2015-06-20 Юниверсити Оф Вашингтон Производные ретиналя и способы их применения для лечения нарушений зрения
JP5271540B2 (ja) 2005-01-20 2013-08-21 インスティチュート フォー モレキュラー メディスン インコーポレイテッド メチルフェニデート誘導体を含む治療剤及び医薬組成物
EP2462959B1 (de) 2005-07-12 2016-06-22 Ampio Pharmaceuticals, Inc. Verfahren und Produkte zur Behandlung von Erkrankungen
CA2669832A1 (en) 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
DK2425839T3 (en) 2009-06-22 2014-11-17 Ampio Pharmaceuticals Inc A method for the treatment of diseases
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
WO2012147497A1 (ja) * 2011-04-27 2012-11-01 株式会社メニコン 人工硝子体材料
WO2014063155A1 (en) 2012-10-21 2014-04-24 University Of Rochester Thy1 (cd90) as a novel therapy to control adipose tissue accumulation
KR20150105355A (ko) 2012-12-19 2015-09-16 앰피오 파마슈티컬스 인코퍼레이티드 질병을 치료하기 위한 방법
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
JP7517988B2 (ja) 2018-01-26 2024-07-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗ｖｅｇｆ剤を使用した血管新生障害の治療のための方法および組成物
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
MX2022006241A (es) 2019-11-25 2022-08-22 Univ California Inhibidores de vegf de accion prolongada para la neovascularizacion intraocular.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
CA2150554A1 (en) * 1992-12-02 1994-06-09 Sheng-Wan Tsao Cyclodextrin and polymer based drug delivery system
US5652209A (en) * 1994-04-29 1997-07-29 University Of Miami Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy
US5431907A (en) * 1994-08-03 1995-07-11 Abelson; Mark B. Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents
WO1997041844A1 (en) * 1996-05-09 1997-11-13 Alcon Laboratories, Inc. Combinations of angiostatic compounds
WO1998010758A1 (en) * 1996-09-13 1998-03-19 The Regents Of The University Of California Methods for treatment of retinal diseases
JPH1180024A (ja) * 1997-09-12 1999-03-23 Toagosei Co Ltd 角膜血管新生阻害剤
US5948801A (en) * 1998-03-09 1999-09-07 Alcon Laboratories, Inc. Treatment of retinal edema with brinzolamide
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
EP1040837A3 (de) * 1999-02-26 2002-01-02 Erasmus Universiteit Rotterdam Medikamente zur Behandlung von Erkrankungen der Aderhaut des Auges

Also Published As

Publication number Publication date
DE60130872T2 (de) 2008-07-17
KR20010113918A (ko) 2001-12-28
WO2001068053A2 (en) 2001-09-20
DE60130872D1 (de) 2007-11-22
WO2001068053A3 (en) 2002-08-29
EP1261317A2 (de) 2002-12-04
EP1938799B1 (de) 2013-05-08
EP1938799A1 (de) 2008-07-02
AU4006601A (en) 2001-09-24
JP2003529567A (ja) 2003-10-07
EP1261317B1 (de) 2007-10-10
MXPA01011346A (es) 2002-09-02
AU785285B2 (en) 2006-12-21
CA2373237A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
ATE375141T1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
ATE323482T1 (de) Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten
DE60138137D1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
ATE362363T1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
TW200633709A (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
ATE478669T1 (de) Zusammenstellungen und methoden zur behandlung der alzheimerschen krankheit, schäden des zentralnervensystems und entzündlichen erkrankungen
ATE492279T1 (de) Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen
DE60101265D1 (de) Behandlung von augenschmerzen
ATE221781T1 (de) Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
MXPA05008561A (es) Uso de esteroides para tratar personas que sufren de trastornos oculares.
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
ATE428470T1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
DE69912304D1 (de) Verwendung von staurosporine derivaten zur behandlung von okularen neovaskularen erkrankungen
ATE513471T1 (de) Verfahren und zusammensetzungen zur behandlung von erkrankungen
ATE425967T1 (de) Piperazin und piperadin-derivate fur die behandlung von neurologischen krankheiten
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
NO20045089L (no) Substituerte aminoalkanfosfonsyrer for behandling av neuropatisk smerte, affektive og oppmerksomhetsforstyrrelser, schizofreni, tinnitus, myopi og andre okulaere lidelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties